title: Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma.
abstract: Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has not been defined or standardized, further complicating the care of these patients. We present a diagnostically challenging case of HEHE where we utilized capecitabine and bevacizumab as another novel treatment option.
authors.affiliation: Yuma Regional Medical Center, Yuma Regional Cancer Center, 2375 S Ridgeview Dr, Yuma, AZ 85364.
authors.forename: Augustine
authors.initials: A
authors.lastname: Lau
authors.affiliation: University of Arizona Cancer Center, Department of Medicine, Division of Hematology/Oncology, Tucson, AZ, USA.
authors.forename: Steve
authors.initials: S
authors.lastname: Malangone
authors.affiliation: University of Arizona Cancer Center, Department of Medicine, Division of Hematology/Oncology, Tucson, AZ, USA.
authors.forename: Myke
authors.initials: M
authors.lastname: Green
authors.affiliation: Yuma Regional Medical Center Yuma Regional Cancer Center, Yuma, AZ, USA.
authors.forename: Ambuga
authors.initials: A
authors.lastname: Badari
authors.affiliation: University of Arizona Cancer Center, Department of Medicine, Division of Hematology/Oncology, Tucson, AZ, USA.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Clarke
authors.affiliation: University of Arizona, College of Medicine and University of Arizona Cancer Center, Department of Medicine, Division of Hematology/Oncology, Tucson, AZ, USA.
authors.forename: Emad
authors.initials: E
authors.lastname: Elquza
keywords: bevacizumab; capecitabine; epithelioid; hemangioendothelioma; heptatic; metastatic